Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation

被引:58
|
作者
Woodrow, James P. [1 ]
Shlobin, Oksana A. [2 ]
Barnett, Scott D. [2 ]
Burton, Nelson [2 ]
Nathan, Steven D. [2 ]
机构
[1] Walter Reed Army Med Ctr, Dept Internal Med, Washington, DC 20307 USA
[2] Inova Fairfax Hosp, Lung Transplant Program, Falls Church, VA USA
来源
关键词
lung transplantation; chronic rejection; chronic lung allograft dysfunction; bronchiolitis obliterans; bronchiolitis obliterans syndrome; AZITHROMYCIN THERAPY; RECIPIENTS; STANDARDIZATION;
D O I
10.1016/j.healun.2010.05.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The radiographic presence of allograft infiltrates is atypical of bronchiolitis obliterans (BO) and inconsistent with the definition of bronchiolitis obliterans requires that restrictive processes are ruled out. The natural history of these other forms of chronic allograft dysfunction has not been well characterized. We examined the prognostic significance of radiographic and spirometric restrictive processes in comparison to BOS among lung transplant recipients. METHODS: We performed a retrospective review of lung transplant recipients with chronic lung allograft dysfunction (CLAD) as defined by spirometry. Subgroups based on the presence or absence of persistent radiographic abnomalities were labeled as non-specific (CLAD-NS) and CLAD due to BOS (CLAD-BOS), respectively. The CLAD-BOS group was further divided into obstructive (OBOS) and restrictive (RBOS) phenotypes' based on spirometry. Groups were compared with respect to survival and decline in forced expiratory volume in l second (FEV(1)). RESULTS: Among 241 lung transplant recipients, 96 (40%) were identified as having CLAD, of whom 62 (65%) had CLAD-BOS and 34 (35%) CLAD-NS. No difference between groups was identified with respect to post-CLAD survival or decline in FEV(1). CLAD-BOS subgroups included 35 (56%) patients with OBOS and 27 (44%) with RBOS. There was no difference in these subgroups with respect to survival or subsequent FEV(1) decline. CONCLUSIONS: Patients with CLAD and persistent radiographic, infiltrates have a similar prognosis to BOS patients but may still represent a clinically distinct phenotype. BOS patients frequently exhibited a restrictive pattern on spirometry, which also did not offer further prognostic information, but could still represent a unique disease phenotype. J Heart Lung Transplant 2010;29:1159-64 (C) 2010 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:1159 / 1164
页数:6
相关论文
共 50 条
  • [2] Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome
    Nobuyuki Yoshiyasu
    Masaaki Sato
    [J]. World Journal of Transplantation, 2020, (05) : 104 - 116
  • [3] Bronchiolitis Obliterans Syndrome Following Lung Transplantation: Economic Burden by Chronic Lung Allograft Dysfunction (CLAD) Stage
    Sheshadri, A.
    Healey, B.
    Sacks, N.
    Wu, E.
    Cyr, P.
    Boerner, G.
    Huang, H.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S70 - S70
  • [4] Prognosis Associated with Bronchiolitis Obliterans Syndrome Compared to Chronic Allograft Dysfunction Following Lung Transplantation
    Woodrow, J. P.
    Shlobin, O. A.
    Ahmad, S.
    Nathan, S. D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [5] Percentage of low attenuation area on computed tomography detects chronic lung allograft dysfunction, especially bronchiolitis obliterans syndrome, after bilateral lung transplantation
    Kubo, Yujiro
    Sugimoto, Seiichiro
    Shiotani, Toshio
    Matsubara, Kei
    Hashimoto, Kohei
    Tanaka, Shin
    Shien, Kazuhiko
    Suzawa, Ken
    Miyoshi, Kentaroh
    Yamamoto, Hiromasa
    Okazaki, Mikio
    Toyooka, Shinichi
    [J]. CLINICAL TRANSPLANTATION, 2023, 37 (11)
  • [6] Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome
    Huang, H. J.
    Yusen, R. D.
    Meyers, B. F.
    Walter, M. J.
    Mohanakumar, T.
    Patterson, G. A.
    Trulock, E. P.
    Hachem, R. R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (11) : 2454 - 2462
  • [7] Impact of primary graft dysfunction on bronchiolitis obliterans syndrome after lung transplantation
    Hachem, R. R.
    Yusen, R. D.
    Patterson, G. A.
    Trulock, E. P.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S109 - S109
  • [8] Azithromycin for Bronchiolitis Obliterans Syndrome after Lung Transplantation
    Vos, R.
    Vanaudenaerde, B. M.
    Schoonis, A.
    Van Raemdonck, D. E.
    Dupont, L. J.
    Verleden, G. M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S94 - S94
  • [9] Montelukast for Bronchiolitis Obliterans Syndrome After Lung Transplantation
    Simons, Sami O.
    Reijers, Monique H.
    [J]. CHEST, 2012, 141 (01) : 275 - 276
  • [10] ALARMINS IN BRONCHIOLITIS OBLITERANS SYNDROME AFTER LUNG TRANSPLANTATION
    Mahida, R. Y.
    Suwara, M.
    Johnson, G.
    Mann, D.
    Corris, P. A.
    Borthwick, L.
    Fisher, A. J.
    [J]. THORAX, 2011, 66 : A26 - A27